CMBA
EXAS

C.M. Bidwell & Associates’s Exact Sciences EXAS Stock Holding History

C.M. Bidwell & Associates’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14
Closed -$1.42K – 496
2025
Q4 		$1.42K Hold
14
– – ﹤0.01% 414
2025
Q3 		$766 Hold
14
– – ﹤0.01% 443
2025
Q2 		$744 Hold
14
– – ﹤0.01% 396
2025
Q1 		$606 Sell
14
-49
-78% -$2.48K ﹤0.01% 400
2024
Q4 		$3.54K Hold
63
– – ﹤0.01% 389
2024
Q3 		$4.29K Hold
63
– – ﹤0.01% 357
2024
Q2 		$2.66K Sell
63
-770
-92% -$42.4K ﹤0.01% 398
2024
Q1 		$57.5K Sell
833
-5
-0.6% -$316 0.04% 219
2023
Q4 		$62K Sell
838
-604
-42% -$39.6K 0.05% 208
2023
Q3 		$98.4K Sell
1,442
-2,374
-62% -$201K 0.07% 234
2023
Q2 		$358K Sell
3,816
-44
-1% -$3.43K 0.26% 64
2023
Q1 		$262K Sell
3,860
-555
-13% -$35.7K 0.2% 86
2022
Q4 		$219K Buy
4,415
+49
+1% +$2K 0.17% 112
2022
Q3 		$142K Buy
4,366
+4,352
+31,086% +$179K 0.12% 156
2022
Q2 		$1K Hold
14
– – ﹤0.01% 460
2022
Q1 		$1K Buy
+14
New +$1.02K ﹤0.01% 498
2018
Q1 		– Sell
-2,230
Closed -$117K – 399
2017
Q4 		$117K Buy
+2,230
New +$119K 0.1% 198

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

C.M. Bidwell & Associates's EXAS Position: Q1 2026 in Review

C.M. Bidwell & Associates sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 14 shares — an estimated $1.42K sold.

C.M. Bidwell & Associates first reported a position in EXAS in Q4 2017 and held it in 17 quarters. The position peaked at $358K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • C.M. Bidwell & Associates reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 14 Exact Sciences shares in Q1 2026, an estimated $1.42K.
  • C.M. Bidwell & Associates first reported a position in Exact Sciences in Q4 2017 and held it in 17 quarters.
  • C.M. Bidwell & Associates's Exact Sciences position peaked at $358K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.